1. Home
  2. PRLD vs PODC Comparison

PRLD vs PODC Comparison

Compare PRLD & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRLD
  • PODC
  • Stock Information
  • Founded
  • PRLD 2016
  • PODC 2013
  • Country
  • PRLD United States
  • PODC United States
  • Employees
  • PRLD N/A
  • PODC N/A
  • Industry
  • PRLD Medicinal Chemicals and Botanical Products
  • PODC
  • Sector
  • PRLD Health Care
  • PODC
  • Exchange
  • PRLD Nasdaq
  • PODC Nasdaq
  • Market Cap
  • PRLD 44.0M
  • PODC 39.6M
  • IPO Year
  • PRLD 2020
  • PODC N/A
  • Fundamental
  • Price
  • PRLD $1.03
  • PODC $1.78
  • Analyst Decision
  • PRLD Strong Buy
  • PODC
  • Analyst Count
  • PRLD 3
  • PODC 0
  • Target Price
  • PRLD $4.00
  • PODC N/A
  • AVG Volume (30 Days)
  • PRLD 231.3K
  • PODC 85.1K
  • Earning Date
  • PRLD 11-05-2025
  • PODC 11-06-2025
  • Dividend Yield
  • PRLD N/A
  • PODC N/A
  • EPS Growth
  • PRLD N/A
  • PODC N/A
  • EPS
  • PRLD N/A
  • PODC N/A
  • Revenue
  • PRLD $7,000,000.00
  • PODC $53,954,000.00
  • Revenue This Year
  • PRLD N/A
  • PODC $17.91
  • Revenue Next Year
  • PRLD N/A
  • PODC $14.41
  • P/E Ratio
  • PRLD N/A
  • PODC N/A
  • Revenue Growth
  • PRLD N/A
  • PODC 17.74
  • 52 Week Low
  • PRLD $0.61
  • PODC $1.10
  • 52 Week High
  • PRLD $2.72
  • PODC $2.94
  • Technical
  • Relative Strength Index (RSI)
  • PRLD 45.61
  • PODC 53.37
  • Support Level
  • PRLD $1.03
  • PODC $1.71
  • Resistance Level
  • PRLD $1.26
  • PODC $1.95
  • Average True Range (ATR)
  • PRLD 0.11
  • PODC 0.15
  • MACD
  • PRLD -0.03
  • PODC 0.03
  • Stochastic Oscillator
  • PRLD 10.34
  • PODC 68.52

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

About PODC PodcastOne Inc.

PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.

Share on Social Networks: